共 111 条
- [1] Walton C., King R., Rechtman L., Kaye W., Leray E., Marrie R. A., Robertson N., La Rocca N., Uitdehaag B., van der Mei I., Wallin M., Helme A., Angood Napier C., Rijke N., Baneke P., Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition, Mult. Scler, 26, pp. 1816-1821, (2020)
- [2] Fletcher J. M., Lalor S. J., Sweeney C. M., Tubridy N., Mills K. H. G., T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Clin. Exp. Immunol, 162, pp. 1-11, (2010)
- [3] Hatton O. L., Harris-Arnold A., Schaffert S., Krams S. M., Martinez O. M., The interplay between Epstein-Barr virus and B lymphocytes: Implications for infection, immunity, and disease, Immunol. Res, 58, pp. 268-276, (2014)
- [4] Abrahamyan S., Eberspacher B., Hoshi M.-M., Aly L., Luessi F., Groppa S., Klotz L., Meuth S. G., Schroeder C., Gruter T., Tackenberg B., Paul F., Then-Bergh F., Kumpfel T., Weber F., Stangel M., Bayas A., Wildemann B., Heesen C., Zettl U., Warnke C., Antony G., Hessler N., Wiendl H., Bittner S., Hemmer B., Gold R., Salmen A., Ruprecht K., German Competence Network Multiple Sclerosis (KKNMS), Other members of the KKNMS that acted as collaborators in this study, Complete Epstein-Barr virus seropo
- [5] Dobson R., Kuhle J., Middeldorp J., Giovannoni G., Epstein-Barr-negative MS: A true phenomenon?, Neurol. Neuroimmunol. Neuroinflamm, 4, (2017)
- [6] Bjornevik K., Cortese M., Healy B. C., Kuhle J., Mina M. J., Leng Y., Elledge S. J., Niebuhr D. W., Scher A. I., Munger K. L., Ascherio A., Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis, Science, 375, pp. 296-301, (2022)
- [7] Soldan S. S., Lieberman P. M., Epstein-Barr virus and multiple sclerosis, Nat. Rev. Microbiol, 21, pp. 51-64, (2023)
- [8] Lanz T. V., Brewer R. C., Ho P. P., Moon J.-S., Jude K. M., Fernandez D., Fernandes R. A., Gomez A. M., Nadj G.-S., Bartley C. M., Schubert R. D., Hawes I. A., Vazquez S. E., Iyer M., Zuchero J. B., Teegen B., Dunn J. E., Lock C. B., Kipp L. B., Cotham V. C., Ueberheide B. M., Aftab B. T., Anderson M. S., DeRisi J. L., Wilson M. R., Bashford-Rogers R. J. M., Platten M., Garcia K. C., Steinman L., Robinson W. H., Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM, Nature
- [9] Angelini D. F., Serafini B., Piras E., Severa M., Coccia E. M., Rosicarelli B., Ruggieri S., Gasperini C., Buttari F., Centonze D., Mechelli R., Salvetti M., Borsellino G., Aloisi F., Battistini L., Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis, PLOS Pathog, 9, (2013)
- [10] van Nierop G. P., Mautner J., Mitterreiter J. G., Hintzen R. Q., Verjans G. M. G. M., Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins, Mult. Scler, 22, pp. 279-291, (2016)